Skip to main content
Premium Trial:

Request an Annual Quote

Janet Woodcock, Alan Krensky, Catherine Deangelis, Karen Holbrooke, Ralph Horwitz, Mary-Claire King, Alan Leshner, John Nelson, Barbara Wolfe

Premium
The US Food and Drug Administration last week said it has promoted deputy commissioner Janet Woodcock to chief medical officer, a newly created spot. She will retain her duties as deputy commissioner, the FDA said.
 
In her dual role, Woodcock will be responsible for scientific and planning-related operations, including organizing, directing, staffing, coordinating, and planning.
 

 
The US National Institutes of Health has appointed Alan Krensky to be its first deputy director for the Office of Portfolio Analysis and Strategic Initiatives, or OPASI. Krensky, who will start the job on July 8, will oversee the Office’s position as an “incubator space to address critical research efforts in cross-cutting areas of NIH priorities,” NIH director Elias Zerhouni said in a statement.
 
OPASI was created to “identify important areas of emerging scientific opportunities or rising public health challenges, and to help accelerate investments in these areas to make sure new ideas have a chance to develop,” according to the NIH. 
 
Krensky comes to OPASI from Stanford University, where he worked at the school of medicine as professor of pediatrics.
 

 
The US National Institutes of Health last week named seven new members to its advisory committee:
 
Catherine Deangelis, editor-in-chief of the Journal of the American Medical Association and fellow at the American Association for the Advancement of Science; Karen Holbrooke, president of Ohio State University and professor of physiology, cell biology, and medicine; Ralph Horwitz, chair of the department of medicine at Stanford University; Mary-Claire King, professor of the American Cancer Society; Alan Leshner, CEO of the American Association for the Advancement of Science and executive publisher of Science; John Nelson, former deputy director of the Utah Department of Health; and Barbara Wolfe, professor of economics, population health sciences, public affairs, and faculty affiliates at the Institute for Research and Poverty at the University of Wisconsin at Madison.

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.